leisure time -WSS

leisure time

author：leisure time 2025-09-29 13:31:22 - browse：2221

Sen. Ron Wyden, D-Ore., left, and Sen. Mike Crapo, R-Idaho, right, walk on Capitol Hill. -- health policy coverage from STAT — Sen. Ron Wyden, D-Ore., left, and Sen. Mike Crapo, R-Idaho, right, walk on Capitol Hill in 2021. Susan Walsh/AP

WASHINGTON — One of the top health care committees in the Senate is assembling ideas for bipartisan legislation to address drug shortages, three Senate aides and three lobbyists told STAT.

The talks, led by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) are in the early days, but they could move the debate over drug shortage reforms into a new phase. The committee has jurisdiction over Medicare and Medicaid payment policies for hospitals. Other committees that have tried tackling the issue have jurisdiction mostly over the Food and Drug Administration.

The panel is tentatively aiming to hold a hearing on the issue in November, the sources said. The panel has also started accepting input from outside stakeholders, one lobbyist said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

WSS

Medicare proceeds with plan to claw back hospital funds

Kidney transplant patients stopped immunosuppressants in trial

FDA scientists endorse Pfizer/BioNTech Covid

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

A controversial new treatment promises to make little people taller

Key Senate panel to consider PBM, drug pricing reform package

leisure time

leisure time

hotspot

Cancer drug shortages should be causing more outrage

Brain injuries and the importance of a second opinion

The high cost of giving birth even with insurance

FDA scientists endorse Pfizer/BioNTech Covid

Wildfire smoke exposes gaps in outdoor worker protections

Brain injuries and the importance of a second opinion

In age of alternative facts, a scholarly course on calling out crap

Medicare proceeds with plan to claw back hospital funds

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Personalized medicine goes far beyond genetics

focus

Pharma showers House GOP doctor with campaign cash

Key Senate panel to consider PBM, drug pricing reform package

Explaining an after

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Sarepta Duchenne therapy fails to meet primary endpoint in trial

What is microchimerism and how does it affect maternal health?

entertainment

Wikipedia

focus

focus